<DOC>
	<DOCNO>NCT01646489</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , affect blood level miravirsen telaprevir administer together .</brief_summary>
	<brief_title>Drug Interaction Study Assess Effect Co-Administered Miravirsen Telaprevir Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Healthy volunteer Weight â‰¤ 85 kg Females nonchildbearing potential ( postmenopausal surgically sterile ) male surgically sterile use acceptable form birth control Current , clinically significant illness medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Antisense</keyword>
	<keyword>miR-122 antagonist</keyword>
	<keyword>Safety healthy volunteer</keyword>
	<keyword>Hepatitis C</keyword>
</DOC>